NASDAQ:MTNB - Matinas Biopharma News Headlines Sign in or create an account to add this stock to your watchlist. Get Started $0.99 +0.01 (+1.02 %) (As of 05/27/2019 06:00 AM ET)Previous Close$0.9882Today's Range$0.96 - $0.989952-Week Range$0.32 - $1.50Volume613,801 shsAverage Volume1.09 million shsMarket Capitalization$141.25 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsChartEarningsInstitutional OwnershipHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Headlines Matinas Biopharma (NASDAQ MTNB) News Headlines Source: All Sources Trusted Sources MarketBeat.com Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance DateHeadlineHave Insiders Been Buying Matinas BioPharma Holdings, Inc. (NYSEMKT:MTNB) Shares?finance.yahoo.com - May 22 at 3:28 PMMatinas BioPharma Announces Abstract Accepted for Presentation at ASM Microbe 2019finance.yahoo.com - May 21 at 3:27 PMViiV Healthcare to evaluate Matinas Bio's LNC platformseekingalpha.com - May 15 at 3:27 PMMatinas BioPharma Holdings, Inc. (MTNB) CEO Jerry Jabbour on Q1, 2019 Results - Earnings Call Transcriptseekingalpha.com - May 14 at 3:31 PMMatinas Biopharma (MTNB) to Release Earnings on Tuesdaywww.americanbankingnews.com - May 12 at 9:33 AMMatinas BioPharma to Host Conference Call and Webcast to Discuss First Quarter 2019 Operational andwww.nasdaq.com - May 8 at 3:26 PMMatinas BioPharma to Host Conference Call and Webcast to Discuss First Quarter 2019 Operational and Financial Results on May 14, 2019finance.yahoo.com - May 8 at 3:26 PMMatinas BioPharma to Ring NYSE Opening Bell® on May 6, 2019finance.yahoo.com - May 2 at 3:25 PMMatinas BioPharma Selected to Present at the BioNJ Ninth Annual BioPartnering Conferencefinance.yahoo.com - May 1 at 3:25 PMMatinas BioPharma Holdings Incwww.bloomberg.com - April 4 at 3:23 PMEdited Transcript of MTNB earnings conference call or presentation 2-Apr-19 12:00pm GMTfinance.yahoo.com - April 2 at 8:24 PMMatinas BioPharma to Present at the 31st Annual ROTH Conferencefinance.yahoo.com - March 18 at 3:20 PMMatinas Bio prices stock offering at $1.10; shares down 6% premarketseekingalpha.com - March 15 at 3:19 PMMatinas BioPharma Announces Pricing of Public Offering of Common Stockfinance.yahoo.com - March 15 at 3:19 PMBRIEF-Matinas Biopharma Q2 loss per share $0.40www.businessinsider.com - August 9 at 1:29 AMInvestor Network: Matinas BioPharma Holdings, Inc. to Host Earnings Callfinance.yahoo.com - August 9 at 1:28 AMMatinas BioPharma Reports 2017 Second Quarter Financial Results and Reaffirms Clinical and Regulatory Strategy to Advance MAT2203 and MAT2501finance.yahoo.com - August 9 at 1:28 AMMatinas BioPharma to Present at the Canaccord Genuity 37th Annual Growth Conferencefinance.yahoo.com - August 4 at 5:49 AMMatinas BioPharma to Host Quarterly Update Conference Callfinance.yahoo.com - August 2 at 6:06 AMHere's Why Matinas BioPharma Holdings Inc. Is Losing Ground Todaywww.fool.com - June 26 at 2:16 PMBRIEF-Matinas Biopharma reports topline data from phase 2 clinical study of vaginal drugwww.reuters.com - June 26 at 8:52 AMMatinas BioPharma Holdings (MTNB) Presents At Jefferies 2017 Global Healthcare Conference - Slideshowseekingalpha.com - June 13 at 6:50 PMMatinas BioPharma Holdings (MTNB) Updates on MAT2203 - Interim Data From NIHMucocutaneous Candidiasis Phase 2 Study - Slideshowseekingalpha.com - June 7 at 8:51 AMMATINAS BIOPHARMA HOLDINGS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disus.rd.yahoo.com - April 3 at 5:58 PMBRIEF-Matinas Biopharma on track to report interim phase 2 data of MAT2203 in June 2017www.reuters.com - April 3 at 10:03 AMMatinas BioPharma Reports 2016 Financial Results and Provides Corporate Updatewww.nasdaq.com - April 3 at 10:03 AMMatinas Biopharma reports FY16 results; shares up 8% premarketseekingalpha.com - April 3 at 10:03 AMQ4 2016 Matinas BioPharma Holdings Inc Earnings Release - Before Market Openbiz.yahoo.com - April 3 at 10:03 AMMATINAS BIOPHARMA HOLDINGS, INC. Files SEC form 10-K, Annual Reportbiz.yahoo.com - March 31 at 6:47 PMMATINAS BIOPHARMA HOLDINGS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosbiz.yahoo.com - March 30 at 6:57 PMMatinas BioPharma reports positive topline data from phase 1 study MAT2501; Shares +4%seekingalpha.com - March 28 at 6:28 PMMatinas Biopharma Holdings (MTNB) Presents At 29th Annual ROTH Conferenceseekingalpha.com - March 16 at 7:26 PMMatinas BioPharma Announces Positive Preclinical Efficacy Results of MAT2501 in an In Vitro Model of Mycobacterium abscessus Infectionus.rd.yahoo.com - March 8 at 9:46 AMMatinas BioPharma Announces Trading on NYSE MKT to Commence March 2, 2017us.rd.yahoo.com - February 27 at 5:59 PM8:35 am Matinas BioPharma will commence trading on the NYSE on March 2us.rd.yahoo.com - February 27 at 5:59 PMMatinas Biopharma raises $13.5M through warrant tender offerseekingalpha.com - January 20 at 3:10 AMMATINAS BIOPHARMA HOLDINGS, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities, Regulation FD Disclosurebiz.yahoo.com - January 19 at 10:09 PMMATINAS BIOPHARMA HOLDINGS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Directbiz.yahoo.com - December 21 at 7:32 PMMatinas Biopharma commences dosing in Phase 1 study of lead product candidate MAT2501seekingalpha.com - December 5 at 6:44 PMMatinas BioPharma Registers Shares, Prepares For Critical Trialsseekingalpha.com - November 11 at 6:00 PM This page was last updated on 5/27/2019 by MarketBeat.com StaffFeatured Article: Momentum Indicator: Relative Strength Index Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.